533
Views
1
CrossRef citations to date
0
Altmetric
Special Issue papers: Genitourinary syndrome of menopause

Pelvic floor muscle rehabilitation for genitourinary syndrome of menopause: why, how and when?

, &
Pages 302-308 | Received 31 Jan 2023, Accepted 15 Mar 2023, Published online: 05 Apr 2023

References

  • Portman DJ, Gass, ML, Vulvovaginal Atrophy Terminology Consensus Conference Panel P. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the international society for the study of women’s sexual health and the North American menopause society. J Sexual Med. 2014;11(12):2865–2872.
  • Gandhi J, Chen A, Dagur G, et al. Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. Am J Obstet Gynecol. 2016;215(6):704–711.
  • Nappi RE, Kokot-Kierepa M. Vaginal health: insights, views & attitudes (VIVA)–results from an international survey. Climacteric. 2012;15(1):36–44.
  • Erekson EA, Li F-Y, Martin DK, et al. Vulvovaginal symptoms prevalence in postmenopausal women and relationship to other menopausal symptoms and pelvic floor disorders. Menopause. 2016;23(4):368–375.
  • DiBonaventura M, Luo X, Moffatt M, et al. The association between vulvovaginal atrophy symptoms and quality of life among postmenopausal women in the United States and Western Europe. J Women’s Health. 2015;24(9):713–722.
  • Kingsberg SA, Wysocki S, Magnus L, et al. Vulvar and vaginal atrophy in postmenopausal women: findings from the revive (REal women’s views of treatment options for menopausal vaginal ChangEs) survey. J Sexual Med. 2013;10(7):1790–1799.
  • Nappi RE, Kokot-Kierepa M. Women’s voices in the menopause: results from an international survey on vaginal atrophy. Maturitas. 2010;67(3):233–238.
  • Avis NE, Brockwell S, Randolph JF, et al. Longitudinal changes in sexual functioning as women transition through menopause: results from the study of women’s health across the nation (SWAN). Menopause. 2009;16(3):442–452.
  • Nappi RE, Palacios S. Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause. Climacteric. 2014;17(1):3–9.
  • Nappi RE, Kingsberg S, Maamari R, et al. The closer (clarifying vaginal atrophy’s impact on SEx and relationships) survey: implications of vaginal discomfort in postmenopausal women and in male partners. J Sexual Med. 2013;10(9):2232–2241.
  • Lonnèe‐Hoffmann RA, Dennerstein L, Lehert P, et al. Sexual function in the late postmenopause: a decade of follow‐up in a population‐based cohort of Australian women. J Sexual Med. 2014;11(8):2029–2038.
  • Levine KB, Williams RE, Hartmann KE. Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women. Menopause. 2008;15(4):661–666.
  • Lindau ST, Leitsch SA, Lundberg KL, et al. Older women’s attitudes, behavior, and communication about sex and HIV: a community-based study. J Women’s Health. 2006;15(6):747–753.
  • Gott M, Hinchliff S. How important is sex in later life? The views of older people. Soc Sci Med. 2003;56(8):1617–1628.
  • Lethaby A, Ayeleke RO, Roberts H. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev. 2016;2016(11):CD001500.
  • Edwards D, Panay N. Treating vulvovaginal atrophy/genitourinary syndrome of menopause: How important is vaginal lubricant and moisturizer composition? Climacteric. 2016;19(2):151–161.
  • Bygdeman M, Swahn M. Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women. Maturitas. 1996;23(3):259–263.
  • Nachtigall LE. Comparative study: replens versus local estrogen in menopausal women. Fertil Steril. 1994;61(1):178–180.
  • Chen J, Geng L, Song X, et al. Evaluation of the efficacy and safety of hyaluronic acid vaginal gel to ease vaginal dryness: a multicenter, randomized, controlled, open‐label, parallel‐group, clinical trial. J Sexual Med. 2013;10(6):1575–1584.
  • Pitsouni E, et al. Laser therapy for the genitourinary syndrome of menopause. Syst Rev Meta-Anal Maturitas. 2017;103:78–88.
  • Johnston S, Bouchard C, Fortier M, et al. Guideline no. 422b: menopause and genitourinary health. J Obstet GynaecolCanada. 2021;43(11):1301–1307. e1.
  • Mercier J, Morin M, Zaki D, et al. Pelvic floor muscle training as a treatment for genitourinary syndrome of menopause: a single-arm feasibility study. Maturitas. 2019;125:57–62.
  • Kingsberg SA, Krychman M, Graham S, et al. The women’s empower survey: identifying women’s perceptions on vulvar and vaginal atrophy and its treatment. J Sexual Med. 2017;14(3):413–424.
  • Palma F, Xholli A, Cagnacci A. Management of vaginal atrophy: a real mess. Results from the AGATA study. Gynecol Endocrinol. 2017;33(9):702–707.
  • Bhupathiraju SN, Grodstein F, Stampfer MJ, et al. Vaginal estrogen use and chronic disease risk in the nurses’ health study. Menopause. 2019;26(6):603–610.
  • Constantine GD, Graham S, Lapane K, et al. Endometrial safety of low-dose vaginal estrogens in menopausal women: a systematic evidence review. Menopause. 2019;26(7):800–807.
  • Pershad A, Morris JM, Pace D, et al. Racial disparities in menopausal hormone therapy acceptance: a pilot study. Menopause. 2022;29(11):1263–1268.
  • Bo K, Frawley HC, Haylen BT, et al. An international urogynecological association (IUGA)/International Continence Society (ICS) joint report on the terminology for the conservative and nonpharmacological management of female pelvic floor dysfunction. Int Urogynecol J. 2017;28(2):191–213.
  • Dumoulin C, Morin M, Danieli C. et al. Group-based vs individual pelvic floor muscle training to treat urinary incontinence in older women: a randomized clinical trial. JAMA Intern Med. 2020;180(10):1284–1293.
  • Sran M, Mercier J, Wilson P, et al. Physical therapy for urinary incontinence in postmenopausal women with osteoporosis or low bone density: a randomized controlled trial. Menopause. 2016;23(3):286–293.
  • Kim H, Yoshida H, Suzuki T. The effects of multidimensional exercise treatment on community-dwelling elderly Japanese women with stress, urge, and mixed urinary incontinence: a randomized controlled trial. Int J Nurs Stud. 2011;48(10):1165–1172.
  • Kim H, Suzuki T, Yoshida Y, et al. Effectiveness of multidimensional exercises for the treatment of stress urinary incontinence in elderly community‐dwelling Japanese women: a randomized, controlled, crossover trial. J Am Geriat Soc. 2007;55(12):1932–1939.
  • Sherburn M, Bird M, Carey M, et al. Incontinence improves in older women after intensive pelvic floor muscle training: an assessor‐blinded randomized controlled trial. Neurourol Urodyn. 2011;30(3):317–324.
  • Cody JD, Jacobs ML, Richardson K, et al. Oestrogen therapy for urinary incontinence in post‐menopausal women. Cochrane Database Syst Rev. 2012;(10):CD001405.
  • Abrams P, Andersson K-E, Apostolidis A, et al. 6th international consultation on incontinence. Recommendations of the international scientific committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse and faecal incontinence. Neurourol Urodyn. 2018;37(7):2271–2272.
  • Dumoulin C, Cacciari LP, Hay‐Smith EJC. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev. 2018;2018(10):CD005654.
  • Dumoulin C, Cacciari LP, Mercier J. Keeping the pelvic floor healthy. Climacteric. 2019;22(3):257–262.
  • US Food and Drug Administration, Estrogen and estrogen/progestin drug products to treat vasomotor symptoms and vulvar and vaginal atrophy symptoms–recommendations for clinical evaluation. Center for Drug Evaluation and Research (CDER), Guidance for Industry, ed. U.D.o.H.a.H. Services. 2003.
  • Chao H-T, Chang P-C, Lin Y-K, et al. Longitudinal effects of a combined program of pelvic floor muscle training and yoga on genitourinary symptoms in asian women of older age: a randomized experimental study. Geriatric Nursing. 2022;46:27–38.
  • Capobianco G, Donolo E, Borghero G, et al. Effects of intravaginal estriol and pelvic floor rehabilitation on urogenital aging in postmenopausal women. Arch Gynecol Obstet. 2012;285(2):397–403.
  • Franco MM, Pena CC, de Freitas LM, et al. Pelvic floor muscle training effect in sexual function in postmenopausal women: a randomized controlled trial. J Sexual Med. 2021;18(7):1236–1244.
  • Nazarpour S, Simbar M, Majd MA, et al. Beneficial effects of pelvic floor muscle exercises on sexual function among postmenopausal women: a randomised clinical trial. J Sexual Health. 2018;15(5):396–402.
  • Khosravi A, Riazi H, Simbar M, et al. Effectiveness of Kegel exercise and lubricant gel for improving sexual function in menopausal women: a randomized trial. Europ J Obstet Gynecol Reproduct Biol. 2022;274:106–112.
  • Nazarpour S, Simbar M, Ramezani Tehrani F, et al. Effects of sex education and Kegel exercises on the sexual function of postmenopausal women: a randomized clinical trial. J Sexual Med. 2017;14(7):959–967.
  • Mercier J, Morin M, Tang A, et al. Pelvic floor muscle training: mechanisms of action for the improvement of genitourinary syndrome of menopause. Climacteric. 2020;23(5):468–473.
  • Goldstein I, Alexander JL. Practical aspects in the management of vaginal atrophy and sexual dysfunction in perimenopausal and postmenopausal women. J Sexual Med. 2005;2(s3):154–165.
  • Nyberg M, Egelund J, Mandrup CM, et al. Leg vascular and skeletal muscle mitochondrial adaptations to aerobic high-intensity exercise training are enhanced in the early postmenopausal phase. J Physiol. 2017;595(9):2969–2983.
  • Gavin TP, Kraus RM, Carrithers JA, et al. Aging and the skeletal muscle angiogenic response to exercise in women. GERONA. 2015;70(10):1189–1197.
  • Ignácio Antônio F, Herbert RD, Bø K, et al. Pelvic floor muscle training increases pelvic floor muscle strength more in post-menopausal women who are not using hormone therapy than in women who are using hormone therapy: a randomised trial. J Physiother. 2018;64(3):166–171.
  • Madill S, Pontbriand-Drolet S, Tang A, et al. Effects of PFM rehabilitation on PFM function and morphology in older women. Neurourol Urodynamics. 2013;32(8):1086–1095.
  • Alves FK, Riccetto C, Adami DB, et al. A pelvic floor muscle training program in postmenopausal women: a randomized controlled trial. Maturitas. 2015;81(2):300–305.
  • Stika CS. Atrophic vaginitis. Dermatol Ther. 2010;23(5):514–522.
  • Cyr MP, Dostie R, Camden C, et al. Improvements following multimodal pelvic floor physical therapy in gynecological cancer survivors suffering from pain during sexual intercourse: results from a one-year follow-up mixed-method study. PLoS One. 2022;17(1):e0262844.
  • Yang EJ, Lim J-Y, Rah UW, et al. Effect of a pelvic floor muscle training program on gynecologic cancer survivors with pelvic floor dysfunction: a randomized controlled trial. Gynecol Oncol. 2012;125(3):705–711.
  • Dennerstein L, Dudley EC, Hopper JL, et al. A prospective population-based study of menopausal symptoms. Obstet Gynecol. 2000;96(3):351–358.
  • Diokno AC, Sampselle CM, Herzog AR, et al. Prevention of urinary incontinence by behavioral modification program: a randomized, controlled trial among older women in the community. Clin Trial. 2004;171(3):1165–1171.
  • Pérez-López FR, Phillips N, Vieira-Baptista P, et al. Management of postmenopausal vulvovaginal atrophy: recommendations of the international society for the study of vulvovaginal disease. Gynecolog Endocrinol. 2021;37(8):746–752.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.